# US 8,785,145 B2 · Method for diagnosing gram-negative infections

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 8,785,145 B2
- Document ID: US8785145B2
- Status: Granted
- Kind: B2
- Application number: 13/571,498
- Filed: 2012-08-10
- Published: 2013-02-14
- Granted: 2014-07-22
- Earliest claimed: 2011-08-11
- Assignees: Ingen Biosciences
- Applicants: Karine Yvonne Gabrielle Mignon Godefroy; Hélène Nuyttens; Julie Roge; Damien Yann Marie-Joseph Thomas
- Inventors: Karine Yvonne Gabrielle Mignon Godefroy; Hélène Nuyttens; Julie Roge; Damien Yann Marie-Joseph Thomas
- Web page: https://patentgrep.com/patent/US8785145B2

## CPC

- G01N 33/56916: {Enterobacteria, e.g. shigella, salmonella, klebsiella, serratia}
- G01N 2469/20: Detection of antibodies in sample from host which are directed against antigens from microorganisms
- G01N: INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES (measuring or testing apparatus or processes other than immunoassay, involving enzymes or microorganisms C12M, C12Q)

## Abstract

The invention concerns an in vitro method for determining if an individual is infected by a gram-negative bacterium preferably on prosthesis comprising: (i) detection of antibodies directed against a polypeptide of sequence SEQ ID NO: 2 and antibodies directed against a polypeptide of sequence SEQ ID NO: 4, in a biological sample of the individual, and (ii) deduction therefrom that the individual is infected by a gram-negative bacterium. The invention further concerns the kit for diagnosing of such an infection.

## Claims

### Claim 1

An in vitro method of determining if an individual is infected by a gram-negative bacterium, the method comprising:
(a) detecting antibodies specific to the polypeptide of SEQ ID NO: 2 and antibodies specific to the polypeptide of SEQ ID NO: 4 in a biological sample of the individual, wherein the biological sample is selected from the group consisting of blood, serum, and plasma, and
(b) deducing therefrom that the individual is infected by the gram-negative bacterium, wherein said infection is a biofilm-associated infection and the gram-negative bacterium is from a family selected from the group consisting of Enterobacteriaceae, Pasteurellaceae, and Pseudomonadaceae.

### Claim 2 (depends on 1)

The method of claim 1, wherein said infection is a prosthetic infection in said individual.

### Claim 3 (depends on 1)

The method of claim 1, wherein the antibodies are IgG.

### Claim 4 (depends on 1)

The method of claim 1, wherein said gram-negative bacterium is Pseudomonas aeruginosa, Escherichia coli, Klebsiella oxytoca, Enterobacter cloacae, Enterobacter amnigenus, Serratia marcescens, and Pasteurella multocida.

### Claim 5 (depends on 1)

The method of claim 1, wherein a prosthetic joint implanted in the individual is infected by said gram-negative bacterium.

### Claim 6 (depends on 1)

The method of claim 1, wherein a prosthetic joint implanted in the individual is infected by said gram-negative bacterium, said prosthetic joint being selected from the group consisting of a knee joint, a shoulder joint and a hip joint.

### Claim 7 (depends on 1)

The method of claim 1, wherein the detection of the antibodies specific to the polypeptide of sequence SEQ ID NO: 2 and the antibodies specific to the polypeptide of sequence SEQ ID NO: 4 comprises contacting the biological sample with the polypeptide of SEQ ID NO: 2 and the polypeptide of SEQ ID NO: 4.

### Claim 8 (depends on 1)

The method of claim 1, wherein the individual is under antibiotic treatment.

### Claim 9

An in vitro method of determining if an individual is infected by a gram-negative bacterium, the method comprising:
(a) contacting capture ligands specific to a polypeptide of the amino acid sequence SEQ ID NO: 2 and capture ligands specific to a polypeptide of the amino acid sequence SEQ ID NO: 4 with a biological sample of the individual, wherein the biological sample is selected from the group consisting of blood, serum, and plasma;
(b) determining if said polypeptide of the amino acid sequence SEQ ID NO: 2 is bound to the capture ligands specific to the polypeptide of the amino acid sequence of SEQ ID NO: 2 and if said polypeptide of the amino acid sequence SEQ ID NO: 4 is bound to the capture ligands specific to the polypeptide of the amino acid sequence SEQ ID NO: 4; and
(c) deducing therefrom that the individual is infected by the gram-negative bacterium, wherein said infection is a biofilm-associated infection and the gram-negative bacterium is from a family selected from the group consisting of Enterobacteriaceae, Pasteurellaceae, and Pseudomonadaceae.